Please Login to view Premium Content

Digital Therapeutics (DTx) entered the discourse of digital health nearly a decade ago but have yet to reach a broad consumer market due to lack of mature payment models and support from PBMs. The mainstreaming of DTx at the consumer level still has a distance to go to reach mainstream consumers and lack of payment models is one of the primary constraints.

You must have an active Advisory Service subscription or license to this report to view the full text. If you already have an account, please login below:

Stay up to the minute.